Biogen

Yahoo Finance • 3 months ago

State Street Corp's Strategic Acquisition of Biogen Inc Shares

Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 250,487 shares of Biogen Inc (NASDAQ:BIIB), a prominent player in the biotechnology industry.... Full story

Yahoo Finance • 3 months ago

Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial

Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial Tuesday, UCB SA (OTC:UCBJY) (OTC:UCBJF) and Biogen Inc. (NASDAQ:BIIB) released topline results from the Phase 3 PHOE... Full story

Yahoo Finance • 4 months ago

Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder

Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder Wednesday, Biogen Inc. (NASDAQ:BIIB) revealed topline data from the pivotal cohort (Part B) of the Phase 2/3 DEVOTE study eva... Full story

Yahoo Finance • 5 months ago

Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen

Alcyone's ThecaFlex is an implantable medical device under investigation for routine subcutaneous administration of therapeutics to the cerebrospinal fluid (CSF). The first stage of the pivotal IDE PIERRE trial has been completed. 10 spina... Full story

Yahoo Finance • 5 months ago

Will the Next Batch of Tech Earnings Encourage Investors to Rotate Back In?

Another chance for mega tech to impress investors This week the megacaps get another chance to prove themselves when Microsoft (NASDAQ:MSFT), Amazon (NASDAQ:AMZN), Meta Platforms (NASDAQ:META) and Apple (AAPL?) all report second-quarter e... Full story

Yahoo Finance • 5 months ago

This Biogen Insider Increased Their Holding In The Last Year

Looking at Biogen Inc.'s (NASDAQ:BIIB ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. Although we don't think share... Full story

Yahoo Finance • 6 months ago

Biogen Completes Acquisition of Human Immunology Biosciences

Biogen Inc. CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company focused on targeted... Full story

Yahoo Finance • 7 months ago

The Biggest Publicly Traded Biotech Company

In this article, we will be discussing the biggest publicly traded biotech company that ranks at the top of our free list of the 20 Biggest Publicly Traded Biotech Companies. Biotechnology and Industry 2023: Market Growth, Transformations... Full story

Yahoo Finance • 8 months ago

Morgan Stanley’s Top 15 Stock Picks for 2024

In this article, we'll look into Morgan Stanley's top 15 stock picks for 2024. If you prefer to skip the introduction about the investment bank and its recent business developments, you can just dive straight into Morgan Stanley's Top 5 St... Full story

Yahoo Finance • 8 months ago

10 Most Promising Stocks to Buy Before They Take Off

In this article, we discuss the 10 most promising stocks to buy before they take off. To skip the detailed analysis of the current earnings week, go directly to the 5 Most Promising Stocks to Buy Before They Take Off. Meta Grows Revenue b... Full story

Yahoo Finance • 8 months ago

Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think

It's been a good week for Biogen Inc. (NASDAQ:BIIB) shareholders, because the company has just released its latest first-quarter results, and the shares gained 7.5% to US$209. Biogen reported US$2.3b in revenue, roughly in line with analys... Full story

Yahoo Finance • 9 months ago

12 Best S&P 500 Stocks To Buy According to Analysts

In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts. If you want to skip our coverage of the latest happenings surrounding one of America's most widely followed stock indexes, then you can take a l... Full story

Yahoo Finance • 10 months ago

14 Best Beaten Down Stocks To Buy Right Now

In this piece, we will take a look at the 14 best beaten down stocks to buy right now. If you want to skip our coverage of the latest events in the stock market, then you can take a look at the 5 Best Beaten Down Stocks To Buy Right Now.... Full story

Yahoo Finance • 10 months ago

20 Most Sustainable Companies in the US

In this article, we will look into the 20 most sustainable companies in the US. If you want to skip our detailed analysis, you can go directly to the 5 Most Sustainable Companies in the US. Sustainability Outlook for the US According to... Full story

Yahoo Finance • 11 months ago

UPDATE 1-Biogen gets DOJ subpoena on business operations in foreign countries

(Adds details on subpoena and background in paragraphs 3-4) Feb 14 (Reuters) - Biogen has received a subpoena from the U.S. Department of Justice seeking information relating to the company's business operations in several foreign countri... Full story

Yahoo Finance • 11 months ago

PRIMECAP Management Bolsters Stake in Biogen Inc

Introduction to the Transaction PRIMECAP Management (Trades, Portfolio) has recently increased its investment in Biogen Inc (NASDAQ:BIIB), a notable move that underscores the firm's confidence in the biotechnology company. On December 31,... Full story

Yahoo Finance • 11 months ago

PRIMECAP Management Bolsters Stake in Elanco Animal Health Inc

Recent Acquisition by PRIMECAP Management (Trades, Portfolio) PRIMECAP Management (Trades, Portfolio), a renowned investment firm, has recently increased its investment in Elanco Animal Health Inc (NYSE:ELAN), a key player in the animal h... Full story

Yahoo Finance • 11 months ago

Biogen Plunges as Alzheimer Drug’s Slow Uptake Signals Reset

(Bloomberg) -- Biogen Inc. fell the most in two years as its latest foray into Alzheimer’s disease got off to a slow start, suggesting a long road to growth for the biotechnology giant. Most Read from Bloomberg Musk Says Putin Can’t Lose... Full story

Yahoo Finance • 11 months ago

Biogen Shares Fall After Results Miss Expectations

Shares of biotechnology pioneer Biogen are down 5% in morning trading after [the biotechnology pioneer](https://www.wsj.com/articles/biogens-new-boss-is-delivering-but-stock-isnt-pricing-it-in-yet-2ad9ceb6) reported declining quarterly sal... Full story

Yahoo Finance • 11 months ago

30 Most Valuable Drug Companies in 2024

In this article, we will take a look at the 30 most valuable drug companies in 2024. If you want to skip our detailed analysis of the pharmaceutical drugs market, you can go directly to 5 Most Valuable Drug Companies in 2024. The Global P... Full story